Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Other Non-Current Assets: 2009-2024

Historic Other Non-Current Assets for Madrigal Pharmaceuticals (MDGL) over the last 7 years, with Dec 2024 value amounting to $5.0 million.

  • Madrigal Pharmaceuticals' Other Non-Current Assets changed negligibly% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $5.0 million for FY2024, which is N/A change from last year.
  • Madrigal Pharmaceuticals' Other Non-Current Assets amounted to $5.0 million in FY2024, which was up 1,539.34% from $305,000 recorded in FY2014.
  • In the past 5 years, Madrigal Pharmaceuticals' Other Non-Current Assets ranged from a high of $5.0 million in FY2024 and a low of $5.0 million during FY2024.
  • Its 1-year average for Other Non-Current Assets is $5.0 million, with a median of $5.0 million in 2024.